Učitavanje...
Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth
Acquired resistance to the estrogen receptor (ER) antagonist tamoxifen, is a major obstacle in treatment of breast cancer. Changes in Zn(2+) accumulation and distribution are associated with tamoxifen-resistance and breast cancer progression. The Zn(2+)-sensing G-protein coupled receptor, ZnR/GPR39,...
Spremljeno u:
| Izdano u: | Sci Rep |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5970167/ https://ncbi.nlm.nih.gov/pubmed/29802348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-26459-5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|